EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC)

Michael Staehler iD, Iulia Blajan, Can Aydogdu iD, Annabel Graser iD, Marina Hoffmann, Isabel Brinkmann, Gerald B Schulz iD, Allen Yen, Jonathan J Cheng, Christoph Fürweger, Sarah P Psutka iD, Raquibul Hannan und 1 weitere

Cancers · 19.03.2026 · 18 (6) · 991

DOI: 10.3390/cancers18060991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 19.03.2026. Verfasst von Michael Staehler und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Munich, D-81377 Munich, Germany. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Radiosurgery (RS) using high-dose hypo-fractionated radiation is a novel treatment for renal cell carcinoma. This study investigates long-term oncological outcomes of RS for upper tract urothelial carcinoma (UTUC) in patients unfit for surgery or with a solitary kidney.

Methods

We performed a retrospective analysis of three prospective institutional databases from tertiary referral centers, including patients with UTUC treated with RS between 2008 and 2024.

Results

The study included 45 patients with a median age of 71.9 years (range 47.8–89.1). Of these, 28 had high-grade disease, and 9 carcinoma in situ (CIS). Twenty-eight patients had a solitary kidney. The median RS dose per fraction was 25 Gy (range 10–25). The median number of fractions was 1 (range 1–4 fractions). The median follow-up was 27.6 months (range 3.1–150.3), and the median overall survival (OS) was 91.7 months (95% CI 72.0–111.5). OS did not correlate with tumor grade or CIS. The median OS for low-grade patients was 52.06 months, while for high-grade patients, it was 87.90 months. Treatment response included complete response in 37 patients (82.2%), partial response in 2 (4.4%), stable disease in 2 (4.4%), and progression in 2 (4.4%). The median baseline and follow-up CKD-EPI were 64.2 and 53.5 mL/min/1.73 m2, respectively. Three patients (6.7%) required hemodialysis.

Conclusions

RS for UTUC is an effective local ablation therapy with durable long-term control and should be considered in patients not suitable for surgical approaches. It should be evaluated as a potential new standard of care in prospective studies in conjunction with peri-interventional systemic therapy.

Schlagwörter

Stichwörter der Autor:innen

hypofractionationorgan sparing treatmentradiosurgeryupper tract urothelial carcinomaurothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, University of Munich, D-81377 Munich, Germany.
  • European Radiosurgery Center Munich (ERCM), D-81377 München, Germany.
  • Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Radiation Oncology, University of Washington, Seattle, WA 98195, USA.
  • Department of Urology, University of Washington, Seattle, WA 98195, USA.

ORCID-Profile: Michael Staehler, Can Aydogdu, Annabel Graser, Gerald B Schulz, Sarah P Psutka

Zitieren

APA

Staehler, M., Blajan, I., Aydogdu, C., Graser, A., Hoffmann, M., Brinkmann, I., Schulz, G. B., Yen, A., Cheng, J. J., Fürweger, C., Psutka, S. P., Hannan, R., & Muacevic, A. (2026). Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC). Cancers, 18(6), 991. https://doi.org/10.3390/cancers18060991

Vancouver

Staehler M, Blajan I, Aydogdu C, Graser A, Hoffmann M, Brinkmann I, et al. Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC). Cancers. 2026;18(6):991. doi:10.3390/cancers18060991

BibTeX
@article{Staehler2026,
  author = {Staehler, Michael and Blajan, Iulia and Aydogdu, Can and Graser, Annabel and Hoffmann, Marina and Brinkmann, Isabel and Schulz, Gerald B and Yen, Allen and Cheng, Jonathan J and Fürweger, Christoph and Psutka, Sarah P and Hannan, Raquibul and Muacevic, Alexander},
  title = {Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC)},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {991},
  doi = {10.3390/cancers18060991}
}
Kostenlos starten →